Clinical Trial
Study Details
Enrollment
133
Interventions
Description
GBT440 will be administered as oral capsules
Name
GBT440
Type
Drug
Description
Matching placebo will be administered as oral capsules
Name
Placebo
Type
Drug
Phase
Phase 1
Status
COMPLETED
Study ID #
NCT02285088
Study Type
Interventional
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of GBT440 compared with placebo in healthy subjects and subjects with sickle cell disease (SCD).
Study Overview
Conditions
Contacts and Locations
Locations
Facility
Guy's Hospital
London
SE1 9RT
United Kingdom
GeoPoint
51.50853, -0.12574